Offshore
Photo
โ Dimitry Nakhla | Babylon Capitalยฎ
RT @DimitryNakhla: A quality valuation analysis on $TMO ๐Ÿง˜๐Ÿฝโ€โ™‚๏ธ

โ€ขNTM P/E Ratio: 22.83x
โ€ข5-Year Mean: 24.89x

โ€ขNTM FCF Yield: 3.89%
โ€ข5-Year Mean: 3.61%

As you can see, $TMO appears to be trading slightly below fair value

Going forward, investors can receive ~9% MORE in earnings per share & ~8% MORE in FCF per share ๐Ÿง ***

Before we get into valuation, letโ€™s take a look at why $TMO is a great business

BALANCE SHEET๐Ÿ†—
โ€ขCash & Short-Term Inv: $5.57B
โ€ขLong-Term Debt: $29.06B

$TMO has a good balance sheet (acquisitions a big growth driver), a A- S&P Credit Rating & 6x FFO Interest Coverage

RETURN ON CAPITALโœ…*
โ€ข2019: 8.3%
โ€ข2020: 13.4%
โ€ข2021: 12.8%
โ€ข2022: 10.3%
โ€ข2023: 8.7%
โ€ข2024: 9.6%

*lower ROIC due to acquisition strategy

RETURN ON EQUITYโœ…
โ€ข2019: 12.9%
โ€ข2020: 19.9%
โ€ข2021: 20.5%
โ€ข2022: 16.4%
โ€ข2023: 13.1%
โ€ข2024: 13.1%

$TMO has strong return metrics, highlighting the financial efficiency of the business

REVENUESโœ…
โ€ข2014: $16.89B
โ€ข2024: $42.88B
โ€ขCAGR: 9.76%

FREE CASH FLOWโœ…
โ€ข2014: $2.19B
โ€ข2024: $7.27B
โ€ขCAGR: 12.74%

NORMALIZED EPSโœ…
โ€ข2014: $6.96
โ€ข2024: $21.86
โ€ขCAGR: 12.12%

SHARE BUYBACKS๐Ÿ†—
โ€ข2014 Shares Outstanding: 402.30M
โ€ขLTM Shares Outstanding: 384.25M

MARGINSโœ…
โ€ขLTM Gross Margins: 42.2%
โ€ขLTM Operating Margins: 18.1%
โ€ขLTM Net Income Margins: 14.8%

***NOW TO VALUATION ๐Ÿง 

As stated above, investors can expect to receive ~9% MORE in EPS & ~8% MORE in FCF per share

Using Benjamin Grahamโ€™s 2G rule of thumb, $TMO has to grow earnings at an 11.42% CAGR over the next several years to justify its valuation

Today, analysts anticipate 2025 - 2027 EPS growth over the next few years to be slightly less than the (11.42%) required growth rate:

2025E: $23.33 (6.7% YoY) *FY Dec
2026E: $25.82 (10.7% YoY)
2027E: $29.11 (12.7% YoY)

$TMO has an excellent track record of meeting analyst estimates ~2 years out, but letโ€™s assume $TMO ends 2027 with $29.11 in EPS & see its CAGR potential assuming different multiples

26x P/E: $756.86๐Ÿ’ต โ€ฆ ~13.2% CAGR

25x P/E: $727.75๐Ÿ’ต โ€ฆ ~11.7% CAGR

24x P/E: $698.64๐Ÿ’ต โ€ฆ ~10.2% CAGR

23x P/E: $669.53๐Ÿ’ต โ€ฆ ~8.5% CAGR

As you can see, $TMO appears to have attractive return potential IF we assume >25x earnings and decent return potential at 24x

Also, $TMO maintains strong support ~20x earnings (roughly 12.4% below todayโ€™s price)

$TMO is an excellent business with a wide moat & will benefit from future ongoing sector demand (AI tailwinds in scientific research), especially their next-gen sequencing machines & chromatography machines

Those buying $TMO today at $532๐Ÿ’ต are buying it for a good price, with some margin of safety

I consider $TMO a strong purchase at $500๐Ÿ’ต (6% below todayโ€™s price) where I can reasonably expect ~11% to ~12% CAGR while assuming a 23x - 24x end multiple, ensuring a comfortable margin of safety

#stocks #investing
___

๐ƒ๐ˆ๐’๐‚๐‹๐Ž๐’๐”๐‘๐„โ€ผ๏ธ: ๐“๐ก๐ข๐ฌ ๐ข๐ฌ ๐๐Ž๐“ ๐ˆ๐ง๐ฏ๐ž๐ฌ๐ญ๐ฆ๐ž๐ง๐ญ ๐€๐๐ฏ๐ข๐œ๐ž. ๐๐š๐›๐ฒ๐ฅ๐จ๐ง ๐‚๐š๐ฉ๐ข๐ญ๐š๐ฅยฎ ๐š๐ง๐ ๐ข๐ญ๐ฌ ๐ซ๐ž๐ฉ๐ซ๐ž๐ฌ๐ž๐ง๐ญ๐š๐ญ๐ข๐ฏ๐ž๐ฌ ๐ฆ๐š๐ฒ ๐ก๐š๐ฏ๐ž ๐ฉ๐จ๐ฌ๐ข๐ญ๐ข๐จ๐ง๐ฌ ๐ข๐ง ๐ญ๐ก๐ž ๐ฌ๐ž๐œ๐ฎ๐ซ๐ข๐ญ๐ข๐ž๐ฌ ๐๐ข๐ฌ๐œ๐ฎ๐ฌ๐ฌ๐ž๐ ๐ข๐ง ๐ญ๐ก๐ข๐ฌ ๐ญ๐ฐ๐ž๐ž๐ญ.

๐“๐ก๐ž ๐ข๐ง๐Ÿ๐จ๐ซ๐ฆ๐š๐ญ๐ข๐จ๐ง ๐œ๐จ๐ง๐ญ๐š๐ข๐ง๐ž๐ ๐ข๐ง ๐ญ๐ก๐ข๐ฌ ๐ญ๐ฐ๐ž๐ž๐ญ ๐ข๐ฌ ๐ข๐ง๐ญ๐ž๐ง๐๐ž๐ ๐Ÿ๐จ๐ซ ๐ข๐ง๐Ÿ๐จ๐ซ๐ฆ๐š๐ญ๐ข๐จ๐ง๐š๐ฅ ๐ฉ๐ฎ๐ซ๐ฉ๐จ๐ฌ๐ž๐ฌ ๐จ๐ง๐ฅ๐ฒ ๐š๐ง๐ ๐ฌ๐ก๐จ๐ฎ๐ฅ๐ ๐ง๐จ๐ญ ๐›๐ž ๐œ๐จ๐ง๐ฌ๐ญ๐ซ๐ฎ๐ž๐ ๐š๐ฌ ๐ข๐ง๐ฏ๐ž๐ฌ๐ญ๐ฆ๐ž๐ง๐ญ ๐š๐๐ฏ๐ข๐œ๐ž ๐ญ๐จ ๐ฆ๐ž๐ž๐ญ ๐ญ๐ก๐ž ๐ฌ๐ฉ๐ž๐œ๐ข๐Ÿ๐ข๐œ ๐ง๐ž๐ž๐๐ฌ ๐จ๐Ÿ ๐š๐ง๐ฒ ๐ข๐ง๐๐ข๐ฏ๐ข๐๐ฎ๐š๐ฅ ๐จ๐ซ ๐ฌ๐ข๐ญ๐ฎ๐š๐ญ๐ข๐จ๐ง. ๐๐š๐ฌ๐ญ ๐ฉ๐ž๐ซ๐Ÿ๐จ๐ซ๐ฆ๐š๐ง๐œ๐ž ๐ข๐ฌ ๐ง๐จ ๐ ๐ฎ๐š๐ซ๐š๐ง๐ญ๐ž๐ž ๐จ๐Ÿ ๐Ÿ๐ฎ๐ญ๐ฎ๐ซ๐ž ๐ซ๐ž๐ฌ๐ฎ๐ฅ๐ญ๐ฌ.

๐ˆ๐ง๐Ÿ๐จ๐ซ๐ฆ๐š๐ญ๐ข๐จ๐ง ๐œ๐จ๐ง๐ญ๐š๐ข๐ง๐ž๐ ๐ข๐ง ๐ญ๐ก๐ข๐ฌ ๐ญ๐ฐ๐ž๐ž๐ญ ๐ก๐š๐ฌ ๐›๐ž๐ž๐ง ๐จ๐›๐ญ๐š๐ข๐ง๐ž๐ ๐Ÿ๐ซ๐จ๐ฆ ๐ฌ๐จ๐ฎ๐ซ๐œ๐ž๐ฌ ๐›๐ž๐ฅ๐ข๐ž๐ฏ๐ž๐ ๐ญ๐จ ๐›๐ž ๐ซ๐ž๐ฅ๐ข๐š๐›๐ฅ๐ž, ๐›๐ฎ๏ฟฝ[...]
Offshore
โ Dimitry Nakhla | Babylon Capitalยฎ RT @DimitryNakhla: A quality valuation analysis on $TMO ๐Ÿง˜๐Ÿฝโ€โ™‚๏ธ โ€ขNTM P/E Ratio: 22.83x โ€ข5-Year Mean: 24.89x โ€ขNTM FCF Yield: 3.89% โ€ข5-Year Mean: 3.61% As you can see, $TMO appears to be trading slightly below fair valueโ€ฆ
๏ฟฝ ๐ข๐ฌ ๐ง๐จ๐ญ ๐ ๐ฎ๐š๐ซ๐š๐ง๐ญ๐ž๐ž๐ ๐š๐ฌ ๐ญ๐จ ๐œ๐จ๐ฆ๐ฉ๐ฅ๐ž๐ญ๐ž๐ง๐ž๐ฌ๐ฌ ๐จ๐ซ ๐š๐œ๐œ๐ฎ๐ซ๐š๐œ๐ฒ.
tweet
Offshore
Photo
โ Stock Analysis Compilation
Baron Health Care Fund on Edgewise Therapeutics, Inc. $EWTX US

Thesis: Edgewise Therapeutics, Inc. is developing innovative drugs for muscle disorders, including sevasetment for Beckerโ€™s and Duchenne muscular dystrophies, and EDG-7500 for hypertrophic cardiomyopathy, showing promising early efficacy and potential market impact.

(Extract from their Q4 letter)
tweet
Offshore
Photo
โ Finding Compounders
Reinvestment and ROIC are the compliments of new value creation https://t.co/KTknJBjfMp
tweet
Offshore
Photo
โ App Economy Insights
$BRK Berkshire's stock portfolio end of 2024. https://t.co/QF1EeuJSO1
tweet
โ Quiver Quantitative
RT @InsiderRadar: ๐ŸšจBREAKING: New Insider Purchase

A director of $JBHT has just reported purchasing $10M of the company's stock, increasing his ownership stake by 110%.

This is the first insider purchase we have seen him report in over 4 years.
tweet
Offshore
Photo
โ Quiver Quantitative
RT @InsiderRadar: $JBLU stock is up 13% so far today, and now up over 22% since this insider purchase from two weeks ago https://t.co/tU0h8kt0kb

๐ŸšจBREAKING: New Insider Purchase

A director of $JBLU has just reported purchasing $614K of the company's stock, increasing his ownership stake by 608%.

This is the first insider purchase we have seen at the company in over 3 years.
- Insider Radar
tweet
Offshore
Photo
โ Hidden Value Gems
RT @HiddenValueGems: Stock screens can occasionally bring up some interesting ideas. Here is what I got with the following parameters:

1โƒฃ Sales 10Y CAGR > 5%
2โƒฃ EPS 5Y CAGR>10%
3โƒฃ ROE>20%
4โƒฃ ROA>5%
5โƒฃ PE<20

scroll below for some extra charts ๐Ÿงต๐Ÿ‘‡

1/3 https://t.co/ldwvgdrclt
tweet
Offshore
Photo
โ Quiver Quantitative
RT @InsiderRadar: $ARDX stock is up 10% today, and almost 30% in total since we reported this insider purchase last month https://t.co/0EYZYD7M9q

๐ŸšจBREAKING: New Insider Purchase

A director of $ARDX, a biotech company, has just reported purchasing $1M of the company's stock.

This is the 3rd insider purchase we have seen him report in the last two months, each for $1M.
- Insider Radar
tweet
AkhenOsiris
Checked in with a couple of my semi/AI buyside skeptics today. They have been nervous about CY26 since middle of last year (and positioned accordingly). Less nervous as of this moment, have yet to put any significant money back into names outside of TSM.
tweet